Human Immunodeficiency Virus Type 1 (HIV-1) antibody
Quick Overview for Human Immunodeficiency Virus Type 1 (HIV-1) antibody (ABIN112755)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Sodium sulfate precipitation and ion-exchange chromatography.
-
Immunogen
- Purified native gp120 from strain IIIB
-
-
-
-
Application Notes
-
ELISA and Western blotting (1/1000). In addition, this product may be used in place of neat antiserum in almost any appropriateantibody-based technique. It is also suitable for conjugation purposes.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 4-5 mg/mL (OD280, E0.1% = 1.4)
-
Buffer
- 0.01 M PBS, pH 7.2 with 0.09 % sodium azide as preservative. No stabilizing proteins have been added.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Human Immunodeficiency Virus Type 1 (HIV-1)
-
Alternative Name
- HIV-1
-
Target Type
- Virus
-
Background
- HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1
Target
-